Naturally occurring cancer in pet dogs: Important models for developing improved cancer therapy in humans

被引:67
作者
Knapp, DW [1 ]
Waters, DJ [1 ]
机构
[1] PURDUE UNIV,DEPT VET CLIN SCI,HARRIS ANIM CANC LAB,W LAFAYETTE,IN 47907
来源
MOLECULAR MEDICINE TODAY | 1997年 / 3卷 / 01期
关键词
D O I
10.1016/S1357-4310(96)20031-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been said that 'dog is man's best friend'. Comparative oncologists are demonstrating that pet dogs could hold the keys for advances in cancer treatment in people, Specific types of cancer that arise spontaneously in pet dogs could serve as important models of human cancer, having much greater similarity to their counterparts in humans than many currently used experimentally Induced tumor models. In vivo models that are relevant to human cancer are greatly needed, particularly for evaluating new strategies for cancer therapy such as augmentation of the immune system or blockade of the metastatic cascade. In addition, pet dogs could also be used to identify environmental carcinogens by acting as sentinels of cancer Induced by these toxins.
引用
收藏
页码:8 / 11
页数:4
相关论文
共 14 条
[1]  
BRONSON RT, 1982, AM J VET RES, V43, P2057
[2]   MESOTHELIOMA IN PET DOGS ASSOCIATED WITH EXPOSURE OF THEIR OWNERS TO ASBESTOS [J].
GLICKMAN, LT ;
DOMANSKI, LM ;
MAGUIRE, TG ;
DUBIELZIG, RR ;
CHURG, A .
ENVIRONMENTAL RESEARCH, 1983, 32 (02) :305-313
[3]  
JIA SF, 1996, P AM ASSOC CANC RES, V37, P499
[4]   PIROXICAM THERAPY IN 34 DOGS WITH TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER [J].
KNAPP, DW ;
RICHARDSON, RC ;
CHAN, TCK ;
BOTTOMS, GD ;
WIDMER, WR ;
DENICOLA, DB ;
TECLAW, R ;
BONNEY, PL .
JOURNAL OF VETERINARY INTERNAL MEDICINE, 1994, 8 (04) :273-278
[5]   PHASE-I TRIAL OF PIROXICAM IN 62 DOGS BEARING NATURALLY-OCCURRING TUMORS [J].
KNAPP, DW ;
RICHARDSON, RC ;
BOTTOMS, GD ;
TECLAW, R ;
CHAN, TCK .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 29 (03) :214-218
[6]  
KNAPP DW, 1995, KIRKS CURRENT VET TH, V12, P1016
[7]   THERAPY FOR OSTEO-SARCOMA IN DOGS WITH INTRAVENOUS-INJECTION OF LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE [J].
MACEWEN, EG ;
KURZMAN, ID ;
ROSENTHAL, RC ;
SMITH, BW ;
MANLEY, PA ;
ROUSH, JK ;
HOWARD, PE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (12) :935-938
[8]  
Malawer MM, 1993, CANCER PRINCIPLES PR, P1509
[9]  
Montironi R, 1996, CANCER, V78, P362, DOI 10.1002/(SICI)1097-0142(19960715)78:2<362::AID-CNCR28>3.3.CO
[10]  
2-I